The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes
Open accessAbstract
Sézary syndrome is a rare leukemic form of cutaneous T cell lymphoma characterized by generalized redness, scaling, itching and increased numbers of circulating atypical T lymphocytes. It is rarely curable, with poor prognosis. Here we present a multiplatform genomic analysis of 37 patients with Sézary syndrome that implicates dysregulation of cell cycle checkpoint and T cell signaling. Frequent somatic alterations were identified in TP53, CARD11, CCR4, PLCG1, CDKN2A, ARID1A, RPS6KA1 and ZEB1. Activating CCR4 and CARD11 mutations were detected in nearly one-third of patients. ZEB1, encoding a transcription repressor essential for T cell differentiation, was deleted in over one-half of patients. IL32 and IL2RG were overexpressed in nearly all cases. Our results demonstrate profound disruption of key signaling pathways in Sézary syndrome and suggest potential targets for new therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1027 · Cited by 5,294
Discovery and saturation analysis of cancer genes across 21 tumour types
Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096
Olsen, E., Vonderheid, E., Pimpinelli, N., Willemze, R., Kim, Y., Knobler, R., Zackheim, H., Duvic, M., Estrach, T., Lamberg, S., et al. (2007) · Blood · doi:10.1182/blood-2007-03-055749 · Cited by 1,429
Self-citationLohr, J. G., Stojanov, P., Lawrence, M. S., Auclair, D., Chapuy, B., Sougnez, C., Cruz-Gordillo, P., Knoechel, B., Asmann, Y. W., Slager, S. L., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121343109 · Cited by 974
Thiers, B. H. (2008) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)70989-4 · Cited by 974
Identification of novel transcripts in annotated genomes using RNA-Seq
Roberts, A., Pimentel, H., Trapnell, C., & Pachter, L. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr355 · Cited by 972
Okazaki, T., Chikuma, S., Iwai, Y., Fagarasan, S., & Honjo, T. (2013) · Nature Immunology · doi:10.1038/ni.2762 · Cited by 916
RNA-SeQC: RNA-seq metrics for quality control and process optimization
DeLuca, D. S., Levin, J. Z., Sivachenko, A., Fennell, T., Nazaire, M.-D., Williams, C., Reich, M., Winckler, W., & Getz, G. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts196 · Cited by 899
Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma
Lenz, G., Davis, R. E., Ngo, V. N., Lam, L., George, T. C., Wright, G. W., Dave, S. S., Zhao, H., Xu, W., Rosenwald, A., et al. (2008) · Science · doi:10.1126/science.1153629 · Cited by 867
Agar, N. S., Wedgeworth, E., Crichton, S., Mitchell, T. J., Cox, M., Ferreira, S., Robson, A., Calonje, E., Stefanato, C. M., Wain, E. M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.7665 · Cited by 853
Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases
Bradford, P. T., Devesa, S. S., Anderson, W. F., & Toro, J. R. (2009) · Blood · doi:10.1182/blood-2008-10-184168 · Cited by 709
Kim, Y. H., Liu, H. L., Mraz-Gernhard, S., Varghese, A., & Hoppe, R. T. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.7.857 · Cited by 653
deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data
McPherson, A., Hormozdiari, F., Zayed, A., Giuliany, R., Ha, G., Sun, M. G. F., Griffith, M., Heravi Moussavi, A., Senz, J., Melnyk, N., et al. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1001138 · Cited by 557
Campbell, J. J., Clark, R. A., Watanabe, R., & Kupper, T. S. (2010) · Blood · doi:10.1182/blood-2009-11-251926 · Cited by 519
Resident memory T cells in human health and disease
Clark, R. A. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010641 · Cited by 446
Genomic landscape of cutaneous T cell lymphoma
Choi, J., Goh, G., Walradt, T., Hong, B. S., Bunick, C. G., Chen, K., Bjornson, R. D., Maman, Y., Wang, T., Tordoff, J., et al. (2015) · Nature Genetics · doi:10.1038/ng.3356 · Cited by 428
CCR4 and its ligands: from bench to bedside
Yoshie, O., & Matsushima, K. (2015) · International Immunology · doi:10.1093/intimm/dxu079 · Cited by 427
Immunopathogenesis and therapy of cutaneous T cell lymphoma
Kim, E. J., Hess, S., Richardson, S. K., Newton, S., Showe, L. C., Benoit, B. M., Ubriani, R., Vittorio, C. C., Junkins-Hopkins, J. M., Wysocka, M., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24826 · Cited by 413
The Pathogenesis of Mycosis Fungoides
Girardi, M., Heald, P. W., & Wilson, L. D. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032810 · Cited by 389
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)
Jawed, S. I., Myskowski, P. L., Horwitz, S., Moskowitz, A., & Querfeld, C. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.07.049 · Cited by 381
The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes
Huether, R., Dong, L., Chen, X., Wu, G., Parker, M., Wei, L., Ma, J., Edmonson, M. N., Hedlund, E. K., Rusch, M. C., et al. (2014) · Nature Communications · doi:10.1038/ncomms4630 · Cited by 379
CARMA1 is a critical lipid raft–associated regulator of TCR-induced NF-κB activation
Gaide, O., Favier, B., Legler, D. F., Bonnet, D., Brissoni, B., Valitutti, S., Bron, C., Tschopp, J., & Thome, M. (2002) · Nature Immunology · doi:10.1038/ni830 · Cited by 343
The MAGUK Family Protein CARD11 Is Essential for Lymphocyte Activation
Hara, H., Wada, T., Bakal, C., Kozieradzki, I., Suzuki, S., Suzuki, N., Nghiem, M., Griffiths, E. K., Krawczyk, C., Bauer, B., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00148-1 · Cited by 336
Phosphorylation of CARMA1 Plays a Critical Role in T Cell Receptor-Mediated NF-κB Activation
Matsumoto, R., Wang, D., Blonska, M., Li, H., Kobayashi, M., Pappu, B., Chen, Y., Wang, D., & Lin, X. (2005) · Immunity · doi:10.1016/j.immuni.2005.10.007 · Cited by 295
A requirement for CARMA1 in TCR-induced NF-κB activation
Wang, D., You, Y., Case, S. M., McAllister-Lucas, L. M., Wang, L., DiStefano, P. S., Nuñez, G., Bertin, J., & Lin, X. (2002) · Nature Immunology · doi:10.1038/ni824 · Cited by 292
Self-citationLong-term Outcomes of 1,263 Patients with Mycosis Fungoides and Sézary Syndrome from 1982 to 2009
Talpur, R., Singh, L., Daulat, S., Liu, P., Seyfer, S., Trynosky, T., Wei, W., & Duvic, M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0604 · Cited by 289
Self-citationDevelopment of αβ T cells in the human thymus
Spits, H. (2002) · Nature Reviews Immunology · doi:10.1038/nri913 · Cited by 279
Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2
Ungewickell, A., Bhaduri, A., Rios, E., Reuter, J., Lee, C. S., Mah, A., Zehnder, A., Ohgami, R., Kulkarni, S., Armstrong, R., et al. (2015) · Nature Genetics · doi:10.1038/ng.3370 · Cited by 277
Jackow, C. M., Cather, J. C., Hearne, V., Asano, A. T., Musser, J. M., & Duvic, M. (1997) · Blood · doi:10.1182/blood.v89.1.32 · Cited by 270
Self-citationDistinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell‐cycle control
Nagl, N. G., Wang, X., Patsialou, A., Van Scoy, M., & Moran, E. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601541 · Cited by 236
Mycosis fungoides—a disease of antigen persistence
TAN, R. S.-H., BUTTERWORTH, C. M., McLAUGHLIN, H., MALKA, S., & SAMMAN, P. D. (1974) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1974.tb12449.x · Cited by 231
Duvic, M., Pinter-Brown, L. C., Foss, F. M., Sokol, L., Jorgensen, J. L., Challagundla, P., Dwyer, K. M., Zhang, X., Kurman, M. R., Ballerini, R., et al. (2015) · Blood · doi:10.1182/blood-2014-09-600924 · Cited by 230
Self-citationPLCG1 mutations in cutaneous T-cell lymphomas
Vaqué, J. P., Gómez-López, G., Monsálvez, V., Varela, I., Martínez, N., Pérez, C., Domínguez, O., Graña, O., Rodríguez-Peralto, J. L., Rodríguez-Pinilla, S. M., et al. (2014) · Blood · doi:10.1182/blood-2013-05-504308 · Cited by 229
Novel somatic and germline mutations in intracranial germ cell tumours
Wang, L., Yamaguchi, S., Burstein, M. D., Terashima, K., Chang, K., Ng, H.-K., Nakamura, H., He, Z., Doddapaneni, H., Lewis, L., et al. (2014) · Nature · doi:10.1038/nature13296 · Cited by 227
Self-citationNovel and Highly Recurrent Chromosomal Alterations in Sézary Syndrome
Vermeer, M. H., van Doorn, R., Dijkman, R., Mao, X., Whittaker, S., van Voorst Vader, P. C., Gerritsen, M.-J. P., Geerts, M.-L., Gellrich, S., Söderberg, O., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6398 · Cited by 197
From human genome to cancer genome: The first decade
Wheeler, D. A., & Wang, L. (2013) · Genome Research · doi:10.1101/gr.157602.113 · Cited by 175
Self-citationNi, X., Jorgensen, J. L., Goswami, M., Challagundla, P., Decker, W. K., Kim, Y. H., & Duvic, M. A. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0830 · Cited by 167
Self-citationScarisbrick, J. J., Kim, Y. H., Whittaker, S. J., Wood, G. S., Vermeer, M. H., Prince, H. M., & Quaglino, P. (2014) · British Journal of Dermatology · doi:10.1111/bjd.12909 · Cited by 154
E2F-associated chromatin modifiers and cell cycle control
Blais, A., & Dynlacht, B. D. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.10.003 · Cited by 146
Impairment of T Cell Development in δ EF1 Mutant Mice
Higashi, Y., Moribe, H., Takagi, T., Sekido, R., Kawakami, K., Kikutani, H., & Kondoh, H. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.8.1467 · Cited by 146
Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma
Nakagawa, M., Schmitz, R., Xiao, W., Goldman, C. K., Xu, W., Yang, Y., Yu, X., Waldmann, T. A., & Staudt, L. M. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20140987 · Cited by 143
Clonal heterogeneity in mycosis fungoides and its relationship to clinical course
Vega, F., Luthra, R., Medeiros, L. J., Dunmire, V., Lee, S., Duvic, M. A., & Jones, D. M. (2002) · Blood · doi:10.1182/blood.v100.9.3369 · Cited by 137
Self-citationEstablishment of Fibroblast Cultures
Takashima, A. (1998) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0201s00 · Cited by 136
Vidulich, K. A., Talpur, R., Bassett, R. L., & Duvic, M. A. (2009) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2009.03771.x · Cited by 115
Self-citationMolecular cytogenetic characterization of Sézary syndrome
Mao, X., Lillington, D. M., Czepulkowski, B. H., Russell‐Jones, R., Young, B. D., & Whittaker, S. J. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10152 · Cited by 100
CDKN2A–CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma
Laharanne, E., Chevret, E., Idrissi, Y., Gentil, C., Longy, M., Ferrer, J., Dubus, P. R., Jouary, T., Vergier, B., Beylot-Barry, M., et al. (2010) · Modern Pathology · doi:10.1038/modpathol.2009.196 · Cited by 99
Independent Repressor Domains in ZEB Regulate Muscle and T-Cell Differentiation
Postigo, A. A., & Dean, D. C. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.7961 · Cited by 93
Caprini, E., Cristofoletti, C., Arcelli, D., Fadda, P., Citterich, M. H., Sampogna, F., Magrelli, A., Censi, F., Torreri, P., Frontani, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2367 · Cited by 79
Down-regulation of TCF8 is involved in the leukemogenesis of adult T-cell leukemia/lymphoma
Hidaka, T., Nakahata, S., Hatakeyama, K., Hamasaki, M., Yamashita, K., Kohno, T., Arai, Y., Taki, T., Nishida, K., Okayama, A., et al. (2008) · Blood · doi:10.1182/blood-2008-01-131185 · Cited by 77
Cutaneous T-Cell Lymphoma: Roles for Chemokines and Chemokine Receptors
Wu, X.-S., Lonsdorf, A. S., & Hwang, S. T. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.45 · Cited by 70
Nakahata, S., Yamazaki, S., Nakauchi, H., & Morishita, K. (2010) · Oncogene · doi:10.1038/onc.2010.172 · Cited by 69
Jones, C. L., Wain, E. M., Chu, C.-C., Tosi, I., Foster, R., McKenzie, R. C. T., Whittaker, S. J., & Mitchell, T. J. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.301 · Cited by 66
Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome
Braun, F., Grabarczyk, P., Möbs, M., Braun, F., Eberle, J., Beyer, M., Sterry, W., Busse, F., Schröder, J., Delin, M., et al. (2011) · Leukemia · doi:10.1038/leu.2011.101 · Cited by 58
Nam, H.-J., Kim, S., Lee, M., Lee, B., Hara, T., Saya, H., Cho, H., & Lee, J. H. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.03.008 · Cited by 35
The tumour suppressor p53 is frequently nonfunctional in Sézary syndrome
Lamprecht, B., Kreher, S., Möbs, M., Sterry, W., Dörken, B., Janz, M., Assaf, C., & Mathas, S. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10918.x · Cited by 34
Ohmatsu, H., Humme, D., Gulati, N., Gonzalez, J., Möbs, M., Suárez‐Fariñas, M., Cardinale, I. R., Mitsui, H., Guttman‐Yassky, E., Sterry, W., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0199-t · Cited by 20
Integrated Genomic Analysis of Sézary Syndrome
Mao, X., Chaplin, T., & Young, B. D. (2011) · Genetics Research International · doi:10.4061/2011/980150 · Cited by 7
Sézary syndrome: an overview of current and future treatment options
Venkatarajan, S., & Duvic, M. A. (2014) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2014.928616 · Cited by 1
Self-citation
Cited by
T cell receptor (TCR) signaling in health and disease
Shah, K., Al-Haidari, A., Sun, J., & Kazi, J. U. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00823-w · Cited by 604
Vallois, D., Dobay, M. P. D., Morin, R. D., Lemonnier, F., Missiaglia, E., Juilland, M., Iwaszkiewicz, J., Fataccioli, V., Bisig, B., Roberti, A., et al. (2016) · Blood · doi:10.1182/blood-2016-02-698977 · Cited by 324
Phospholipase C families: Common themes and versatility in physiology and pathology
Katan, M., & Cockcroft, S. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101065 · Cited by 89
Metadata
- Authors
- Wang, L., Ni, X., Covington, K. R., Yang, B. Y., Shiu, J., Zhang, X., Xi, L., Meng, Q., Langridge, T., Drummond, J., Donehower, L. A., Doddapaneni, H., Muzny, D. M., Gibbs, R. A., Wheeler, D. A., & Duvic, M.
- Venue
- Nature Genetics
- Published
- 2015-11-09
- Volume
- 47
- Issue
- 12
- Pages
- 1426-1434
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2195886524
- Cited by
- 323
- References
- 62
- FWCI
- 30.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.